Blood DNA methylation and breast cancer risk: a prospective nested case–control study

Juan Rodriguez, Felix Grassmann, Damien Kaukonen, Sara Hägg, Keith Humphreys, Mikael Eriksson, Yuqi Zhang, Katharina Morawitz, Marike Gabrielson, Per Hall, Kamila Czene · 2026

Read Blood DNA methylation and breast cancer risk: a prospective nested case–control study by Juan Rodriguez, Felix Grassmann, Damien Kaukonen, Sara Hägg, Keith Humphreys, Mikael Eriksson, Yuqi Zhang, Katharina Morawitz, Marike Gabrielson, Per Hall, Kamila Czene (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13320414.txt.

Description

Juan Rodriguez and co-authors build a blood gene tag score for breast cancer risk in a 2026 study inside a Swedish screening plan. A blood test that flags risk years before a tumor shows could sharpen who gets close screening. Chemical tags on DNA in blood stay steady over time and may catch early body shifts that precede tumors.

Blood from 377 women who later grew breast cancer and 378 matched peers was scanned across a wide tag chip. A first city set gave 87 tag sites tied to later risk, and 22 of them held up in a second city set and formed the score. The score tracked risk across tumor types, stood apart from known risk factors, and held steady up to five years before diagnosis. It matched a gene risk score and lifted short term sorting.

Catalog record

CREATORJuan Rodriguez, Felix Grassmann, Damien Kaukonen, Sara Hägg, Keith Humphreys, Mikael Eriksson, Yuqi Zhang, Katharina Morawitz, Marike Gabrielson, Per Hall, Kamila Czene
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48978
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13320414

Browse the full library · About the Tower of Babel